StreetAlpha.app
Home › Stocks › FTRE

Fortrea Holdings Inc. (FTRE)

Healthcare
$18.55
▼ −7.94%
LAST CLOSE · NOV 20

Fortrea provides clinical trial and drug development services to pharmaceutical, biotechnology and medical device companies. It last closed at $18.55 on Nov 20, down 7.94% on the day. The next earnings report for FTRE is expected around Thu, Feb 25, 2027. For the quarter ended Sep 2026, FTRE reported EPS of $0.01 on revenue of $691.5M, with revenue down 1.4% from a year ago. Over its last 8 reports the stock moved an average of 12.4% the session after earnings. Over the last 12 months FTRE insiders bought $0 of stock on the open market and sold $4.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is FTRE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold FTRE.

Key Stats

Last 12 months
Results
Revenue
$2.7B
−3.4% vs a year ago
Net income
−$68.7M
−2.6% margin
EPS (diluted)
−$0.66
Free cash flow
$169.0M
6.3% margin
Valuation
Market cap
$1.8B
96.5M shares
P/E
–
No P/E while losing money
Price to sales
0.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$220.6M
At Sep 30
Debt
$1.1B
At Sep 30
Shareholder equity
$532.3M
Shares outstanding
96.5M
At Oct 27
Employees19,000 (Sep 30, 2023)
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $3.1B$3.1BFY2021FY2022: $2.8B$2.8BFY2022FY2023: $2.8B$2.8BFY2023FY2024: $2.7B$2.7BFY2024FY2025: $2.7B$2.7BFY2025

From FTRE's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 25
Estimated date · Time not announced
Reported EPS
$0.01
Quarter ended Sep 2026
Year ago EPS
-$0.17
Same quarter last year
Revenue
$691.5M
−1.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.68Dec '24Mar 2025: -$6.25Mar '25Jun 2025: -$4.14Jun '25Sep 2025: -$0.17Sep '25Dec 2025: -$0.28Dec '25Mar 2026: -$0.25Mar '26Jun 2026: -$0.14Jun '26Sep 2026: $0.01Sep '26Latest $0.01
Revenue by quarter
Dec 2024: $697.0MDec '24Mar 2025: $651.3MMar '25Jun 2025: $710.3MJun '25Sep 2025: $701.3MSep '25Dec 2025: $660.5MDec '25Mar 2026: $636.5MMar '26Jun 2026: $678.2MJun '26Sep 2026: $691.5MSep '26Latest $691.5M
How FTRE moved after its last 8 reports
Average move the session after a report ±12.4%
Oct 29, 2026Time not announced−10.6%
Jul 29, 2026Time not announced−1.4%
May 5, 2026Time not announced+18.6%
Feb 26, 2026Time not announced+4.5%
Nov 5, 2025Time not announced+23.2%
Aug 6, 2025Time not announced+0.3%
May 12, 2025Time not announced−15.6%
Mar 3, 2025Time not announced−25.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on FTREStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on FTRE
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on FTRE

Technical Analysis

FTRE · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 15% below its 20 day and 13% below its 50 day average. It is 14% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 37), near oversold. The nearest support is the swing low (Aug 24) at $17.78, and the nearest resistance the swing high (Aug 20) at $18.77.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 7.6%/day
Key levels
$26.1652 week high+41.0%
$21.2820 day average+14.7%
$21.0250 day average+13.3%
$19.94Pivot R1+7.5%
$19.63100 day average+5.8%
$19.12Pivot+3.1%
$18.77Swing high (Aug 20)+1.2%
$18.55Last close
$17.78Swing low (Aug 24)−4.2%
$17.73Pivot S1−4.4%
$16.00200 day average−13.7%
$8.5552 week low−53.9%
Indicators
RSI (14)37.46Weak, oversold below 30Neutral
MACD-0.54Below its signal lineBearish
Stochastic22.7Middle of its rangeNeutral
ADX (14)19.5No clear trend
Williams %R-94.7Oversold below −80, overbought above −20Oversold
CCI (20)-109.1Oversold below −100, overbought above 100Oversold
Rate of change−15.5%Change over 10 sessionsBearish
ATR (14)$1.41Typical daily range, 7.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for FTRE

What happened before

See how FTRE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow FTRE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How FTRE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for FTREHow many large options trades hit FTRE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

FTRE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●150 buying vs 140 selling
  • ▲Held by funds +3.1 pts
  • ▲Funds holding +13
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding349336+3.9%
In funds' top 1010–
Held by funds106.9%103.8%+3.1 pts
New / increased49 / 10142 / 100+5.6%
Reduced / sold out106 / 34109 / 38−4.8%
Put/call ratio0.000.01−100.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FTRE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

FTRE Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$4.7M17 sales · 6 insiders
2026-02 sold $29K2026-03 sold $138K2026-05 sold $27K2026-06 sold $229K2026-08 sold $4.2M2026-09 sold $57KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 9Mark A. MoraisCOOSale3,149$16.85$53K
Sep 9Carrie Elizabeth RussellInterim CAOSale246$16.85$4K
Aug 19Mark A. MoraisCOOSale4,892$18.19$89K
Aug 6Anshul ThakralCEOSale111,857$18.11$2.0M
Aug 5Anshul ThakralCEOSale99,869$19.16$1.9M
Aug 3Machelle SandersDirectorSale9,700$18.01$175K
Every insider buy and sale for FTRE over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See FTRE insider trades →

From SEC Form 4 filings by FTRE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FTRE is in one of them and how their past FTRE trades turned out.

FTRE in the AI portfolios
Loading…

FTRE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FTRE in an article yet. Here's the latest on the wider market.

FTRE in the news

FTRE Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Jul 24
Who traded FTRE · since 2025
Latest 1 filing
$1K – $15KTraded Jun 23, 2025Filed Jul 24, 2025
PersonTypeAmountTradedFiledDelay
James French HillR · ARSell$1K – $15KJun 23, 2025Jul 24, 202531 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Fortrea Holdings

Fortrea is a contract research organization based in Durham, North Carolina. It provides clinical trial and development services to pharmaceutical, biotechnology and medical device companies. Its offerings include clinical pharmacology studies, full clinical development from early phase through trials after approval, and consulting on product development, regulatory strategy and market access. Customers can choose full service, functional service provider or hybrid delivery models.

Headquarters
Durham, NC